Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion
- PMID: 32703021
- PMCID: PMC8777323
- DOI: 10.1177/1120672120945103
Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion
Conflict of interest statement
Figures
Comment on
-
Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion.Eur J Ophthalmol. 2021 Mar;31(2):548-555. doi: 10.1177/1120672120904669. Epub 2020 Feb 3. Eur J Ophthalmol. 2021. PMID: 32009462
References
-
- Breiman L. Random forests. Mach Learn 2001; 45(1): 5–32.
-
- Rohm M, Tresp V, Müller M, et al.. Predicting visual acuity by using machine learning in patients treated for neovascular age-related macular degeneration. Ophthalmology 2018; 125(7): 1028–1036. - PubMed
-
- Papudesu C, Domalpally A, Oden N, et al.. Ellipsoid zone status and its association with visual acuity in eyes with macular edema in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE 2). Investig Ophthalmol Vis Sci 2019; 60(9): 2590–2590.
-
- Matthe E, Eulitz P, Furashova O. Spectral-domain optical coherence tomography (SD-OCT) findings in retinal vein occlusion–Can retinal ischemia be detected in OCT findings? Investig Ophthalmol Vis Sci 2019; 60(9): 2587–2587.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
